CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
Mo Xiang
MX
Lan
Zhou Xiang
ZX
Zhen
Wei Hai
WH
Ming
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D019002:CD56 Antigen / Q000032:analysis*; D003240:Connective Tissue Diseases / Q000175:diagnosis; D003520:Cyclophosphamide / Q000008:administration & dosage; D003951:Diagnostic Errors; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D005142:Eyelid Neoplasms / Q000473:pathology*; D017809:Fatal Outcome; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D016130:Immunophenotyping; D007694:Killer Cells, Natural / Q000737:chemistry / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D008297:Male; D009666:Nose; D011239:Prednisolone / Q000008:administration & dosage; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000821:virology; D016176:T-Lymphocyte Subsets / Q000737:chemistry / Q000473:pathology* / Q000821:virology; D014750:Vincristine / Q000008:administration & dosage; D055815:Young Adult
D019002:CD56 Antigen; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone